Latest Industry study on Contract Research Organizations , Industry Global Hormone Replacement Therapy Market Analysis

Global Hormone Replacement Therapy Market Analysis by Therapy (Estrogen Hormone Replacement,
Growth Hormone Replacement, Thyroid Hormone Replacement, and Testosterone replacement), by
Route of Administration (Oral, Parenteral, and Others); by Type of Disease (Menopause,
Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others); by Geography
(North America, Europe, Asia Pacific, Latin America and Middle East & Africa) to 2025
The Hormone Replacement Therapy market has substantial growth over the past few years owing to rise
in rising awareness on post-menopausal among women, increasing novel delivery systems for drug
delivery, presence of regularly monitored formulations, and increasing aging population are expected to
boost the market growth. Additionally, advantages associated with the hormone replacement therapy
such as reduction in risk incidence of osteoporosis, cardiovascular disease, and reduction of vasomotor
symptoms are also expected to drive the growth of hormone replacement therapy market in the coming
years. Though, high cost for therapy, some of the side-effects, lack of products due to weak pipeline,
and risk of cancer are expected to hamper the market growth during the forecast period.
Get Free 10 % Customization in this Report @ https://globalmarketforecasts.com/request-for-
sample/35
The -201cGlobal Hormone Replacement Therapy Market Analysis and Forecasts to 2025-201d can be
segmented into therapy, route of administration, type of disease, and region. Based on the therapy, the
market can be categorized as estrogen hormone replacement, growth hormone replacement, thyroid
hormone replacement, and testosterone replacement. More than 60%, the estrogen replacement
therapy segment dominates the market. Estrogen replacement therapy is the largest market due to the
increasing number of women reaching menopausal age is projected to drive the demand for these
treatments over coming years. The testosterone replacement therapy is mainly chosen by elderly male
patients suffering from hypogonadism. The market based on route of administration can be segmented
into oral, parenteral, and some others. Parenteral hormone replacement therapy is the major segment
and is anticipated to witness lucrative growth over the forecast timeline. The parenteral route of
administration is normally used for delivery of drugs like Nutropin, Signifor, Genotropin, and Tev-Tropin.
Moreover, in the case of testosterone drugs, the oral route of administration is most usually chosen. The
oral route of administration is considered as one of the safest and preferred routes of drug
administration.
On the basis of type of disease, the market can be categorized as menopause, hypothyroidism, male
hypogonadism, growth hormone deficiency, and others. Menopause hormone replacement is estimated
to be the fastest growing over the forecast period. Menopause occurs in most womens lives when
menstrual periods stop permanently, and the woman is no longer able to have kids. In those who have
had operation to remove the uterus but still have ovaries, menopause usually arises at the time of the
surgery or when hormone levels fall. Menopause naturally occurs between 45 and 55 years of age. It is
trailed by hypothyroidism, male hypogonadism and growth hormone deficiency.
Top 10 Players Genomics Market Overview:
Sociedad Qu-00edmica y Minera de Chile S.A.,